Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Foslevodopa/Foscarbidopa REal-world Evidence in Parkinson's Disease Quality of LIFE Outcomes

NCT06965374 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT06965374
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06965374 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Foslevodopa/Foscarbidopa REal-world Evidence in Parkinson's Disease Quality of LIFE Outcomes
Lead sponsor
AbbVie
Phase
Observational
Overall status
Recruiting
Start date
June 4, 2025
Completion date
June 30, 2027
Enrollment
270 (estimated)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease